1 The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer Lung Cancer, May 17, 2013 Review Article
2 Eating Disorders with and without Comorbid Depression and Anxiety: Similarities and Differences in a Clinical Sample of Children and Adolescents European Eating Disorders Review, May 17, 2013
3 ED management of patients with eating disorders The American Journal of Emergency Medicine, April 30, 2013 Review Article
4 A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma World Journal of Surgical Oncology, May 1, 2013
5 Safety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer Journal of Korean Medical Science, May 21, 2013
6 A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin's lymphoma, multiple myeloma, or Castleman's disease Clinical Cancer Research, May 14, 2013
7 A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer Clinical Cancer Research, May 13, 2013
8 A systematic review of evidence for psychological treatments in eating disorders: 2005-2012 International Journal of Eating Disorders, May 13, 2013 Evidence Based Medicine Review Article
9 Managing physical risk in anorexia nervosa Advances in Psychiatric Treatment, May 2, 2013 Review Article
10 Is outpatient cognitive remediation therapy feasible to use in randomized clinical trials for anorexia nervosa? International Journal of Eating Disorders, May 6, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor